UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 1, 2010
SPECTRUM PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter)
| |
|
|
|
|
Delaware
(State or other jurisdiction
of incorporation)
|
|
000-28782
(Commission File
Number)
|
|
93-0979187
(I.R.S. Employer
Identification No.) |
701 N. Green Valley Parkway, Suite 265
Henderson, Nevada 89074
(Address of principal executive offices) (Zip Code)
(702) 990-3266
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 8.01. — Other Events.
On April 1, 2010, Spectrum Pharmaceuticals, Inc. (the “Company”) issued a press release
announcing that it missed the deadline of March 31, 2010, for the filing of its 2009 Annual
Report on Form 10-K with the U.S. Securities & Exchange
Commission, as additional time is necessary
to finalize its financial statements for the year ended December 31, 2009. The Company expects to
file the Annual Report on Form 10-K shortly.
A copy of the press release is filed as Exhibit 99.1 to this report and incorporated herein by
reference.
2